Private Prostate Cancer Screening UK: PSA, MRI and Costs (2026)

Private prostate cancer screening in the UK: PSA, MRI and what each test actually does

Prostate cancer is the most common cancer in UK men. About 1 in 8 will be diagnosed in their lifetime. Most cases are found late — partly because the NHS doesn’t run a routine screening programme, and partly because the symptoms (or lack of them) catch men off guard.

If you’re trying to figure out whether to screen privately, this guide cuts through the noise. Below: what each test does, what it costs, when each one makes sense, and what to do with the result.

The short answer

There are three main private prostate screening tests in the UK:

• PSA blood test — cheapest (£40–£90), most common, but high false-positive rate

• Multiparametric prostate MRI — far more accurate (£600–£900), increasingly the gold standard before biopsy

• MRI-targeted biopsy — only done if MRI shows a suspicious area (£1,500–£3,000 private)

For most men over 50, or over 45 with risk factors, a sensible private screening package combines a PSA blood test with a clinician review. MRI is added if PSA is raised or symptoms suggest it. Biopsy is reserved for cases where imaging shows a lesion.

Why the NHS doesn’t routinely screen

The NHS doesn’t offer routine prostate cancer screening because PSA — the standard screening blood test — has well-documented problems:

• High false-positive rate (raised PSA from benign causes is common)

• High false-negative rate (some prostate cancers don’t raise PSA)

• Risk of overdiagnosis (finding cancers that wouldn’t have caused harm)

• Past biopsy practices caused real harm

That position is shifting. Multiparametric MRI before biopsy has changed the calculation: it makes screening much safer and more accurate. Several research bodies are now pushing the NHS to introduce targeted screening for higher-risk men. Until that happens, screening for most UK men means going privately.

You can request a PSA test from your NHS GP if you’re over 50 and ask for one — they’re legally allowed to do this on request, but it’s not proactively offered.

The PSA blood test

What it does: measures Prostate-Specific Antigen, a protein made by the prostate. The level rises with prostate cancer — but also with benign enlargement, infections, recent sex, recent cycling, and just getting older.

Cost privately: £40–£90 standalone, or included in many men’s health screens

Strengths: - Cheap, quick, low risk - Reliable trending tool if repeated over years - Can pick up cancer years before symptoms

Weaknesses: - Around 75% of men with a raised PSA don’t have cancer - Around 15% of men with prostate cancer have a normal PSA - A single PSA result in isolation is hard to interpret

How to interpret: PSA is age-banded. Very rough thresholds for “concerning”: - Under 50: above 2.5 ng/ml - 50–59: above 3.5 ng/ml - 60–69: above 4.5 ng/ml - 70+: above 6.5 ng/ml

But context matters more than the number. A PSA of 4.0 that has doubled in 12 months is more concerning than a stable PSA of 5.5. This is why one-off PSAs sold direct-to-consumer are clinically less useful than PSAs interpreted by a GP who can compare results over time.

Multiparametric prostate MRI

What it does: detailed scan of the prostate using multiple MRI sequences. Modern reporting uses the PI-RADS scoring system (1–5) to grade the likelihood of significant cancer.

Cost privately: £600–£900

Strengths: - Far more accurate than PSA alone - Can rule out cancer in many men with raised PSA, avoiding unnecessary biopsy - Identifies suspicious areas to target if biopsy is needed - Non-invasive, no needles, no radiation

Weaknesses: - Expensive - Still misses some cancers (no test is perfect) - Needs a specialist reporter — quality varies - A PI-RADS 3 result (“equivocal”) is a difficult conversation

MRI is now considered the standard of care before biopsy in UK urology. If you’re going to have any prostate biopsy in 2026, it should be MRI-targeted unless there’s a specific reason otherwise.

MRI-targeted biopsy

What it does: if MRI shows a PI-RADS 3, 4 or 5 lesion, a urologist takes tissue samples specifically from that area, usually via the perineum (the area between scrotum and anus). Modern transperineal biopsy is safer than older transrectal techniques.

Cost privately: £1,500–£3,000

Strengths: - Definitive diagnosis - Targeted sampling reduces misses - Transperineal route has much lower infection risk than older techniques

Weaknesses: - Invasive - Some risks (bleeding, infection, urinary issues) - Done under local or general anaesthetic

Who should consider private screening, and when

Higher risk groups (screen earlier and more often): - Black men of African or Caribbean descent — roughly double the lifetime risk - Men with a father or brother diagnosed with prostate cancer - Men with multiple family cancers (BRCA gene families)

For these groups, sensible private screening starts around age 45.

Average risk: - Most men should consider their first private PSA around age 50 - A clinical conversation with a GP first — discussing the trade-offs — is more useful than a blind blood test

Symptoms that should not wait for routine screening: - Difficulty starting urination, weak stream, dribbling - Frequent or urgent urination, especially at night - Blood in urine or semen - Erectile dysfunction with no other cause - Persistent pelvic, back or bone pain

These can have benign causes — but in any man over 40, they warrant a GP appointment and likely a PSA.

Typical private screening packages

Basic prostate check (£60–£150): - PSA blood test - GP consultation to interpret result - Discussion of family history and risk factors

Comprehensive men’s health screen (£200–£600): - PSA + full blood count, kidney, liver, lipids, diabetes - Testosterone (some packages) - ECG (some packages) - Clinician review

Prostate MRI (£600–£900): - Multiparametric MRI of the prostate - PI-RADS-scored radiology report - Follow-up consultation to interpret

Full prostate workup (£900–£1,400): - PSA blood test - Prostate MRI - Urology or GP review combining both results - Onward referral pathway if biopsy is needed

At Northwest Health, prostate screening is part of our private GP service with private blood tests and access to private MRI imaging when indicated.

What to do with the result

Normal PSA, no symptoms: Repeat in 1–2 years if average risk, annually if high risk.

Mildly raised PSA, no symptoms: Don’t panic. Repeat in 6–8 weeks (avoiding recent sex, cycling, infection). If still raised, consider prostate MRI.

Significantly raised PSA, or rapidly rising: MRI is the next step. Don’t go straight to biopsy.

PI-RADS 1–2 on MRI: Reassuring. Continue routine surveillance.

PI-RADS 3: Equivocal. Discuss options with a urologist — repeat MRI in 6 months or proceed to biopsy.

PI-RADS 4–5: Targeted biopsy recommended.

A private GP can coordinate the whole pathway and refer to a urologist if and when needed. You don’t have to jump straight to a specialist on a raised PSA.

Frequently asked questions

Can I just buy a PSA test online? You can, but it’s clinically less useful in isolation. A PSA without context — your age, family history, symptoms, previous results, and a clinician to interpret a raised number — can cause more anxiety than insight.

Is the digital rectal exam (DRE) still useful? Less so than it used to be. PSA and MRI have largely replaced DRE for screening. Some clinicians still do it for context but it’s not the main diagnostic tool any more.

Should I have a PSA test if I have no symptoms? This is the central question, and it’s a personal decision. Pros: catches some cancers early, can be reassuring. Cons: false positives cause anxiety and tests, some cancers found wouldn’t have caused harm. A GP conversation before the blood test helps you decide.

Does an enlarged prostate (BPH) cause raised PSA? Yes. Benign prostatic hyperplasia is the most common cause of mildly raised PSA in older men. It’s not cancer, but it can complicate interpretation.

How fast does prostate cancer grow? Most prostate cancers are slow-growing. Some are aggressive. The grade (Gleason score) and stage at diagnosis matter far more than how long they’ve been there. Early detection of aggressive disease is the prize.

Can I claim private prostate screening on health insurance? Some policies cover symptomatic investigation but not asymptomatic screening. Always pre-authorise before booking.

Are there genetic tests for prostate cancer risk? Yes, including BRCA testing if there’s strong family cancer history. A GP can refer for genetic counselling if appropriate.

In summary

Private prostate screening in the UK is mostly about three tests: PSA blood test, multiparametric prostate MRI, and (when imaging suggests it) targeted biopsy. Costs range from £40 for a basic PSA to several thousand pounds for a full workup including biopsy.

The single most useful step isn’t picking a test — it’s having a proper clinical conversation before you screen. A GP who understands your risk factors, family history and symptoms can save you years of anxiety, unnecessary tests, and the wrong test at the wrong time.

About the author

Dr Chun Tang (MBChB, MRCGP, MBA) is a GMC-registered private GP and co-founder of Northwest Health in Bamber Bridge, Preston. His clinical interests include men’s health, cancer screening, and preventive medicine. He has been featured in The Daily Telegraph, The Mirror, BBC and GB News.

Considering prostate screening?Book a private GP consultation to discuss the right pathway for your age, risk factors and symptoms — before deciding which test to have.